APO Research, Inc.

APO RESEARCH · REPORT

Obeticholic Acid Drug

Selected research

Market Analysis & Forecast

Global Obeticholic Acid Drug Market Analysis and Forecast 2026-2032

Market perspective

The global Obeticholic Acid Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Obeticholic Acid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Obeticholic Acid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Obeticholic Acid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Obeticholic Acid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Obeticholic Acid Drug include Intercept Pharmaceuticals and Dainippon Sumitomo Pharma etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Obeticholic Acid Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Obeticholic Acid Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Obeticholic Acid Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Obeticholic Acid Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Obeticholic Acid Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Obeticholic Acid Drug sales, projected growth trends, production technology, application and end-user industry.

Obeticholic Acid Drug Segment by Company

Intercept Pharmaceuticals

Dainippon Sumitomo Pharma

Obeticholic Acid Drug Segment by Type

5mg

10mg

Obeticholic Acid Drug Segment by Application

Primary Biliary Cirrhosis

Nonalcoholic Fatty Liver Disease

Other

Obeticholic Acid Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obeticholic Acid Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Obeticholic Acid Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obeticholic Acid Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Obeticholic Acid Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Obeticholic Acid Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Obeticholic Acid Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Obeticholic Acid Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5mg Major Manufacturers Table 3. 10mg Major Manufacturers Table 4. Global Obeticholic Acid Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Primary Biliary Cirrhosis Major Manufacturers Table 6. Nonalcoholic Fatty Liver Disease Major Manufacturers Table 7. Other Major Manufacturers Table 8. Obeticholic Acid Drug Industry Trends Table 9. Obeticholic Acid Drug Industry Drivers Table 10. Obeticholic Acid Drug Industry Opportunities and Challenges Table 11. Obeticholic Acid Drug Industry Restraints Table 12. Global Obeticholic Acid Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Obeticholic Acid Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Obeticholic Acid Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Obeticholic Acid Drug Revenue Market Share by Region (2021-2026) Table 16. Global Obeticholic Acid Drug Revenue Market Share by Region (2027-2032) Table 17. Global Obeticholic Acid Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Obeticholic Acid Drug Sales by Region (2021-2026) & (K Units) Table 19. Global Obeticholic Acid Drug Sales by Region (2027-2032) & (K Units) Table 20. Global Obeticholic Acid Drug Sales Market Share by Region (2021-2026) Table 21. Global Obeticholic Acid Drug Sales Market Share by Region (2027-2032) Table 22. Global Obeticholic Acid Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Obeticholic Acid Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Obeticholic Acid Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Obeticholic Acid Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Obeticholic Acid Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Obeticholic Acid Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Obeticholic Acid Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Obeticholic Acid Drug Manufacturers, Product Type & Application Table 30. Global Obeticholic Acid Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Obeticholic Acid Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Obeticholic Acid Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Obeticholic Acid Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Obeticholic Acid Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Obeticholic Acid Drug Revenue Market Share by Type (2021-2026) Table 37. Global Obeticholic Acid Drug Revenue Market Share by Type (2027-2032) Table 38. Global Obeticholic Acid Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Obeticholic Acid Drug Sales by Type (2021-2026) & (K Units) Table 40. Global Obeticholic Acid Drug Sales by Type (2027-2032) & (K Units) Table 41. Global Obeticholic Acid Drug Sales Market Share by Type (2021-2026) Table 42. Global Obeticholic Acid Drug Sales Market Share by Type (2027-2032) Table 43. Global Obeticholic Acid Drug Price by Type (2021-2026) & (US$/Unit) Table 44. Global Obeticholic Acid Drug Price by Type (2027-2032) & (US$/Unit) Table 45. Global Obeticholic Acid Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Obeticholic Acid Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Obeticholic Acid Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Obeticholic Acid Drug Revenue Market Share by Application (2021-2026) Table 49. Global Obeticholic Acid Drug Revenue Market Share by Application (2027-2032) Table 50. Global Obeticholic Acid Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Obeticholic Acid Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Obeticholic Acid Drug Sales by Application (2027-2032) & (K Units) Table 53. Global Obeticholic Acid Drug Sales Market Share by Application (2021-2026) Table 54. Global Obeticholic Acid Drug Sales Market Share by Application (2027-2032) Table 55. Global Obeticholic Acid Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Obeticholic Acid Drug Price by Application (2027-2032) & (US$/Unit) Table 57. Intercept Pharmaceuticals Company Information Table 58. Intercept Pharmaceuticals Business Overview Table 59. Intercept Pharmaceuticals Obeticholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Intercept Pharmaceuticals Obeticholic Acid Drug Product Portfolio Table 61. Intercept Pharmaceuticals Recent Development Table 62. Dainippon Sumitomo Pharma Company Information Table 63. Dainippon Sumitomo Pharma Business Overview Table 64. Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Dainippon Sumitomo Pharma Obeticholic Acid Drug Product Portfolio Table 66. Dainippon Sumitomo Pharma Recent Development Table 67. North America Obeticholic Acid Drug Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Obeticholic Acid Drug Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Obeticholic Acid Drug Sales by Type (2021-2026) & (K Units) Table 70. North America Obeticholic Acid Drug Sales by Type (2027-2032) & (K Units) Table 71. North America Obeticholic Acid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 72. North America Obeticholic Acid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 73. North America Obeticholic Acid Drug Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Obeticholic Acid Drug Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Obeticholic Acid Drug Sales by Application (2021-2026) & (K Units) Table 76. North America Obeticholic Acid Drug Sales by Application (2027-2032) & (K Units) Table 77. North America Obeticholic Acid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 78. North America Obeticholic Acid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 79. North America Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Obeticholic Acid Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Obeticholic Acid Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 83. North America Obeticholic Acid Drug Sales by Country (2021-2026) & (K Units) Table 84. North America Obeticholic Acid Drug Sales by Country (2027-2032) & (K Units) Table 85. North America Obeticholic Acid Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 86. North America Obeticholic Acid Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 87. United States Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 88. Canada Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 89. Europe Obeticholic Acid Drug Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Obeticholic Acid Drug Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Obeticholic Acid Drug Sales by Type (2021-2026) & (K Units) Table 92. Europe Obeticholic Acid Drug Sales by Type (2027-2032) & (K Units) Table 93. Europe Obeticholic Acid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 94. Europe Obeticholic Acid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 95. Europe Obeticholic Acid Drug Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Obeticholic Acid Drug Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Obeticholic Acid Drug Sales by Application (2021-2026) & (K Units) Table 98. Europe Obeticholic Acid Drug Sales by Application (2027-2032) & (K Units) Table 99. Europe Obeticholic Acid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 100. Europe Obeticholic Acid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 101. Europe Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Obeticholic Acid Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. Europe Obeticholic Acid Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. Europe Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 105. Europe Obeticholic Acid Drug Sales by Country (2021-2026) & (K Units) Table 106. Europe Obeticholic Acid Drug Sales by Country (2027-2032) & (K Units) Table 107. Europe Obeticholic Acid Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 108. Europe Obeticholic Acid Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 109. Germany Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 110. France Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 111. U.K. Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 112. Italy Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 113. Netherlands Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 114. China Obeticholic Acid Drug Revenue by Type (2021-2026) & (US$ Million) Table 115. China Obeticholic Acid Drug Revenue by Type (2027-2032) & (US$ Million) Table 116. China Obeticholic Acid Drug Sales by Type (2021-2026) & (K Units) Table 117. China Obeticholic Acid Drug Sales by Type (2027-2032) & (K Units) Table 118. China Obeticholic Acid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 119. China Obeticholic Acid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 120. China Obeticholic Acid Drug Revenue by Application (2021-2026) & (US$ Million) Table 121. China Obeticholic Acid Drug Revenue by Application (2027-2032) & (US$ Million) Table 122. China Obeticholic Acid Drug Sales by Application (2021-2026) & (K Units) Table 123. China Obeticholic Acid Drug Sales by Application (2027-2032) & (K Units) Table 124. China Obeticholic Acid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 125. China Obeticholic Acid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 126. Asia Obeticholic Acid Drug Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Obeticholic Acid Drug Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Obeticholic Acid Drug Sales by Type (2021-2026) & (K Units) Table 129. Asia Obeticholic Acid Drug Sales by Type (2027-2032) & (K Units) Table 130. Asia Obeticholic Acid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Asia Obeticholic Acid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Asia Obeticholic Acid Drug Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Obeticholic Acid Drug Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Obeticholic Acid Drug Sales by Application (2021-2026) & (K Units) Table 135. Asia Obeticholic Acid Drug Sales by Application (2027-2032) & (K Units) Table 136. Asia Obeticholic Acid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Asia Obeticholic Acid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Asia Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Obeticholic Acid Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Obeticholic Acid Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Asia Obeticholic Acid Drug Sales by Country (2021-2026) & (K Units) Table 143. Asia Obeticholic Acid Drug Sales by Country (2027-2032) & (K Units) Table 144. Asia Obeticholic Acid Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Asia Obeticholic Acid Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Japan Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 147. South Korea Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 148. India Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 149. Australia Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 150. China Taiwan Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Obeticholic Acid Drug Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Obeticholic Acid Drug Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Obeticholic Acid Drug Sales by Type (2021-2026) & (K Units) Table 155. SAMEA Obeticholic Acid Drug Sales by Type (2027-2032) & (K Units) Table 156. SAMEA Obeticholic Acid Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 157. SAMEA Obeticholic Acid Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 158. SAMEA Obeticholic Acid Drug Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Obeticholic Acid Drug Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Obeticholic Acid Drug Sales by Application (2021-2026) & (K Units) Table 161. SAMEA Obeticholic Acid Drug Sales by Application (2027-2032) & (K Units) Table 162. SAMEA Obeticholic Acid Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 163. SAMEA Obeticholic Acid Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 164. SAMEA Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Obeticholic Acid Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Obeticholic Acid Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. SAMEA Obeticholic Acid Drug Sales by Country (2021-2026) & (K Units) Table 169. SAMEA Obeticholic Acid Drug Sales by Country (2027-2032) & (K Units) Table 170. SAMEA Obeticholic Acid Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 171. SAMEA Obeticholic Acid Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Brazil Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 173. Argentina Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 174. Chile Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 175. Colombia Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 176. Peru Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 178. Israel Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 179. UAE Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 180. Turkey Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 181. Iran Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 182. Egypt Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Obeticholic Acid Drug Distributors List Table 186. Obeticholic Acid Drug Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Obeticholic Acid Drug Image Figure 2. Global Obeticholic Acid Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Obeticholic Acid Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5mg Image Figure 5. 10mg Image Figure 6. Global Obeticholic Acid Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Obeticholic Acid Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Primary Biliary Cirrhosis Image Figure 9. Nonalcoholic Fatty Liver Disease Image Figure 10. Other Image Figure 11. Global Obeticholic Acid Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Obeticholic Acid Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Obeticholic Acid Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Obeticholic Acid Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Obeticholic Acid Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Obeticholic Acid Drug Sales (2021-2032) & (K Units) Figure 17. Global Obeticholic Acid Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Obeticholic Acid Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Obeticholic Acid Drug Sales YoY (2021-2032) & (K Units) Figure 20. Europe Obeticholic Acid Drug Sales YoY (2021-2032) & (K Units) Figure 21. China Obeticholic Acid Drug Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Obeticholic Acid Drug Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Obeticholic Acid Drug Sales YoY (2021-2032) & (K Units) Figure 24. Global Obeticholic Acid Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Obeticholic Acid Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Obeticholic Acid Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Obeticholic Acid Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Obeticholic Acid Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Obeticholic Acid Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Obeticholic Acid Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Obeticholic Acid Drug Sales Market Share by Type (2021-2032) Figure 33. Global Obeticholic Acid Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Obeticholic Acid Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Obeticholic Acid Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Obeticholic Acid Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Obeticholic Acid Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Obeticholic Acid Drug Sales Market Share by Application (2021-2032) Figure 39. North America Obeticholic Acid Drug Revenue Share by Type (2021-2032) Figure 40. North America Obeticholic Acid Drug Sales Share by Type (2021-2032) Figure 41. North America Obeticholic Acid Drug Revenue Share by Application (2021-2032) Figure 42. North America Obeticholic Acid Drug Sales Share by Application (2021-2032) Figure 43. North America Obeticholic Acid Drug Revenue Share by Country (2021-2032) Figure 44. North America Obeticholic Acid Drug Sales Share by Country (2021-2032) Figure 45. Europe Obeticholic Acid Drug Revenue Share by Type (2021-2032) Figure 46. Europe Obeticholic Acid Drug Sales Share by Type (2021-2032) Figure 47. Europe Obeticholic Acid Drug Revenue Share by Application (2021-2032) Figure 48. Europe Obeticholic Acid Drug Sales Share by Application (2021-2032) Figure 49. Europe Obeticholic Acid Drug Revenue Share by Country (2021-2032) Figure 50. Europe Obeticholic Acid Drug Sales Share by Country (2021-2032) Figure 51. China Obeticholic Acid Drug Revenue Share by Type (2021-2032) Figure 52. China Obeticholic Acid Drug Sales Share by Type (2021-2032) Figure 53. China Obeticholic Acid Drug Revenue Share by Application (2021-2032) Figure 54. China Obeticholic Acid Drug Sales Share by Application (2021-2032) Figure 55. Asia Obeticholic Acid Drug Revenue Share by Type (2021-2032) Figure 56. Asia Obeticholic Acid Drug Sales Share by Type (2021-2032) Figure 57. Asia Obeticholic Acid Drug Revenue Share by Application (2021-2032) Figure 58. Asia Obeticholic Acid Drug Sales Share by Application (2021-2032) Figure 59. Asia Obeticholic Acid Drug Revenue Share by Country (2021-2032) Figure 60. Asia Obeticholic Acid Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Obeticholic Acid Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Obeticholic Acid Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Obeticholic Acid Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Obeticholic Acid Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Obeticholic Acid Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Obeticholic Acid Drug Sales Share by Country (2021-2032) Figure 67. Obeticholic Acid Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Obeticholic Acid Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
Applications
  • Primary Biliary Cirrhosis
  • Nonalcoholic Fatty Liver Disease
  • Other
Companies covered
  • Intercept Pharmaceuticals
  • Dainippon Sumitomo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Obeticholic Acid Drug Market by Type
  3. 1.2.1 Global Obeticholic Acid Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5mg
  5. 1.2.3 10mg
  6. 1.3 Obeticholic Acid Drug Market by Application
  7. 1.3.1 Global Obeticholic Acid Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Primary Biliary Cirrhosis
  9. 1.3.3 Nonalcoholic Fatty Liver Disease
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Obeticholic Acid Drug Market Dynamics
  1. 2.1 Obeticholic Acid Drug Industry Trends
  2. 2.2 Obeticholic Acid Drug Industry Drivers
  3. 2.3 Obeticholic Acid Drug Industry Opportunities and Challenges
  4. 2.4 Obeticholic Acid Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Obeticholic Acid Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Obeticholic Acid Drug Revenue by Region
  3. 3.2.1 Global Obeticholic Acid Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Obeticholic Acid Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Obeticholic Acid Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Obeticholic Acid Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Obeticholic Acid Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Obeticholic Acid Drug Sales by Region
  9. 3.4.1 Global Obeticholic Acid Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Obeticholic Acid Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Obeticholic Acid Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Obeticholic Acid Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Obeticholic Acid Drug Revenue by Manufacturers
  2. 4.1.1 Global Obeticholic Acid Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Obeticholic Acid Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Obeticholic Acid Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Obeticholic Acid Drug Sales by Manufacturers
  6. 4.2.1 Global Obeticholic Acid Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Obeticholic Acid Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Obeticholic Acid Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Obeticholic Acid Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Obeticholic Acid Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Obeticholic Acid Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Obeticholic Acid Drug Manufacturers, Product Type & Application
  13. 4.7 Global Obeticholic Acid Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Obeticholic Acid Drug Market CR5 and HHI
  16. 4.8.2 2025 Obeticholic Acid Drug Tier 1, Tier 2, and Tier 3
5 Obeticholic Acid Drug Market by Type
  1. 5.1 Global Obeticholic Acid Drug Revenue by Type
  2. 5.1.1 Global Obeticholic Acid Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Obeticholic Acid Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Obeticholic Acid Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Obeticholic Acid Drug Sales by Type
  6. 5.2.1 Global Obeticholic Acid Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Obeticholic Acid Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Obeticholic Acid Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Obeticholic Acid Drug Price by Type
6 Obeticholic Acid Drug Market by Application
  1. 6.1 Global Obeticholic Acid Drug Revenue by Application
  2. 6.1.1 Global Obeticholic Acid Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Obeticholic Acid Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Obeticholic Acid Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Obeticholic Acid Drug Sales by Application
  6. 6.2.1 Global Obeticholic Acid Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Obeticholic Acid Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Obeticholic Acid Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Obeticholic Acid Drug Price by Application
7 Company Profiles
  1. 7.1 Intercept Pharmaceuticals
  2. 7.1.1 Intercept Pharmaceuticals Company Information
  3. 7.1.2 Intercept Pharmaceuticals Business Overview
  4. 7.1.3 Intercept Pharmaceuticals Obeticholic Acid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Intercept Pharmaceuticals Obeticholic Acid Drug Product Portfolio
  6. 7.1.5 Intercept Pharmaceuticals Recent Developments
  7. 7.2 Dainippon Sumitomo Pharma
  8. 7.2.1 Dainippon Sumitomo Pharma Company Information
  9. 7.2.2 Dainippon Sumitomo Pharma Business Overview
  10. 7.2.3 Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Dainippon Sumitomo Pharma Obeticholic Acid Drug Product Portfolio
  12. 7.2.5 Dainippon Sumitomo Pharma Recent Developments
8 North America
  1. 8.1 North America Obeticholic Acid Drug Market Size by Type
  2. 8.1.1 North America Obeticholic Acid Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Obeticholic Acid Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Obeticholic Acid Drug Price by Type (2021-2032)
  5. 8.2 North America Obeticholic Acid Drug Market Size by Application
  6. 8.2.1 North America Obeticholic Acid Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Obeticholic Acid Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Obeticholic Acid Drug Price by Application (2021-2032)
  9. 8.3 North America Obeticholic Acid Drug Market Size by Country
  10. 8.3.1 North America Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Obeticholic Acid Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Obeticholic Acid Drug Market Size by Type
  2. 9.1.1 Europe Obeticholic Acid Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Obeticholic Acid Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Obeticholic Acid Drug Price by Type (2021-2032)
  5. 9.2 Europe Obeticholic Acid Drug Market Size by Application
  6. 9.2.1 Europe Obeticholic Acid Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Obeticholic Acid Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Obeticholic Acid Drug Price by Application (2021-2032)
  9. 9.3 Europe Obeticholic Acid Drug Market Size by Country
  10. 9.3.1 Europe Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Obeticholic Acid Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Obeticholic Acid Drug Market Size by Type
  2. 10.1.1 China Obeticholic Acid Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Obeticholic Acid Drug Sales by Type (2021-2032)
  4. 10.1.3 China Obeticholic Acid Drug Price by Type (2021-2032)
  5. 10.2 China Obeticholic Acid Drug Market Size by Application
  6. 10.2.1 China Obeticholic Acid Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Obeticholic Acid Drug Sales by Application (2021-2032)
  8. 10.2.3 China Obeticholic Acid Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Obeticholic Acid Drug Market Size by Type
  2. 11.1.1 Asia Obeticholic Acid Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Obeticholic Acid Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Obeticholic Acid Drug Price by Type (2021-2032)
  5. 11.2 Asia Obeticholic Acid Drug Market Size by Application
  6. 11.2.1 Asia Obeticholic Acid Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Obeticholic Acid Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Obeticholic Acid Drug Price by Application (2021-2032)
  9. 11.3 Asia Obeticholic Acid Drug Market Size by Country
  10. 11.3.1 Asia Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Obeticholic Acid Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Obeticholic Acid Drug Market Size by Type
  2. 12.1.1 SAMEA Obeticholic Acid Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Obeticholic Acid Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Obeticholic Acid Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Obeticholic Acid Drug Market Size by Application
  6. 12.2.1 SAMEA Obeticholic Acid Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Obeticholic Acid Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Obeticholic Acid Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Obeticholic Acid Drug Market Size by Country
  10. 12.3.1 SAMEA Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Obeticholic Acid Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Obeticholic Acid Drug Value Chain Analysis
  2. 13.1.1 Obeticholic Acid Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Obeticholic Acid Drug Production Mode & Process
  6. 13.2 Obeticholic Acid Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Obeticholic Acid Drug Distributors
  9. 13.2.3 Obeticholic Acid Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.